Fast Track
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
Article first published online: 30 JUN 2006
DOI: 10.1002/jcb.20982
Copyright © 2006 Wiley-Liss, Inc.
Additional Information
How to Cite
Kutay, H., Bai, S., Datta, J., Motiwala, T., Pogribny, I., Frankel, W., Jacob, S. T. and Ghoshal, K. (2006), Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J. Cell. Biochem., 99: 671–678. doi: 10.1002/jcb.20982
Publication History
- Issue published online: 25 SEP 2006
- Article first published online: 30 JUN 2006
- Manuscript Accepted: 11 APR 2006
- Manuscript Received: 7 APR 2006
Funded by
- NIH. Grant Number: CA86978
Keywords:
- folate/methyl-deficient diet;
- hepatocellular carcinoma;
- microRNA;
- miR-122;
- miR-17-92;
- miR-21
Abstract
MicroRNAs (miRs) are conserved small non-coding RNAs that negatively regulate gene expression. The miR profiles are markedly altered in cancers and some of them have a causal role in tumorigenesis. Here, we report changes in miR expression profile in hepatocellular carcinomas (HCCs) developed in male Fisher rats-fed folic acid, methionine, and choline-deficient (FMD) diet. Comparison of the miR profile by microarray analysis showed altered expression of some miRs in hepatomas compared to the livers from age-matched rats on the normal diet. While let-7a, miR-21, miR-23, miR-130, miR-190, and miR-17-92 family of genes was upregulated, miR-122, an abundant liver-specific miR, was downregulated in the tumors. The decrease in hepatic miR-122 was a tumor-specific event because it did not occur in the rats switched to the folate and methyl-adequate diet after 36 weeks on deficient diet, which did not lead to hepatocarcinogenesis. miR-122 was also silent in a transplanted rat hepatoma. Extrapolation of this study to human primary HCCs revealed that miR-122 expression was significantly (P = 0.013) reduced in 10 out of 20 tumors compared to the pair-matched control tissues. These findings suggest that the downregulation of miR-122 is associated with hepatocarcinogenesis and could be a potential biomarker for liver cancers. J. Cell. Biochem. 99: 671–678, 2006. © 2006 Wiley-Liss, Inc.

1097-4644/asset/olbannerleft.jpg?v=1&s=586aefb5b324d0a899c8338e293753a524cbe672)
